Chemoinformaics analysis of Totarol methyl ether
Molecular Weight | 300.486 | nRot | 2 |
Heavy Atom Molecular Weight | 268.23 | nRig | 15 |
Exact Molecular Weight | 300.245 | nRing | 3 |
Solubility: LogS | -4.441 | nHRing | 0 |
Solubility: LogP | 4.497 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 57.2094 |
nHD | 0 | BPOL | 33.8386 |
QED | 0.603 |
Synth | 1.922 |
Natural Product Likeliness | 0.461 |
NR-PPAR-gamma | 0.163 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.99 |
Pgp-sub | 0.012 |
HIA | 0.015 |
CACO-2 | -4.691 |
MDCK | 0.0000271 |
BBB | 0.532 |
PPB | 0.990818 |
VDSS | 0.94 |
FU | 0.015181 |
CYP1A2-inh | 0.986 |
CYP1A2-sub | 0.145 |
CYP2c19-inh | 0.95 |
CYP2c19-sub | 0.113 |
CYP2c9-inh | 0.849 |
CYP2c9-sub | 0.763 |
CYP2d6-inh | 0.068 |
CYP2d6-sub | 0.69 |
CYP3a4-inh | 0.184 |
CYP3a4-sub | 0.254 |
CL | 10.274 |
T12 | 0.755 |
hERG | 0.462 |
Ames | 0.854 |
ROA | 0.062 |
SkinSen | 0.978 |
Carcinogencity | 0.141 |
EI | 0.567 |
Respiratory | 0.645 |
NR-Aromatase | 0.109 |
Antiviral | No |
Prediction | 0.80461 |